Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Income from Continuing Operations (2024 - 2025)

Connect Biopharma Holdings' Income from Continuing Operations history spans 2 years, with the latest figure at 17200000.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 33.58% year-over-year to 17200000.0; the TTM value through Sep 2025 reached 49277000.0, changed N/A, while the annual FY2024 figure was 15628000.0, 74.84% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 17200000.0 at Connect Biopharma Holdings, down from 12899000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 14847000.0 in Q2 2024 and bottomed at 17200000.0 in Q3 2025.